Loading...
Loading...
Some of the stocks that may grab investor focus today are:
- Wall Street expects Conagra Brands Inc CAG to report quarterly earnings at $0.52 per share on revenue of $2.06 billion before the opening bell. Conagra shares gained 1.21 percent to $38.60 in after-hours trading.
-
Analysts expect Nike Inc NKE to post quarterly earnings at $0.4 per share on revenue of $8.39 billion after the closing bell. Nike shares declined 1.01 percent to close at $63.59 on Wednesday.
- Allergan plc AGN reported that the FDA has accepted NDA for Seysara for treatment of moderate to severe acne. Allergan shares rose 0.05 percent to $165.80 in the after-hours trading session.
- Before the markets open, Finish Line Inc FINL is projected to report quarterly loss at $0.36 per share on revenue of $360.68 million. Finish Line shares gained 2.65 percent to $12.00 in after-hours trading.
- Analysts are expecting Accenture Plc ACN to have earned $1.67 per share on revenue of $9.26 billion in the latest quarter. Accenture will release earnings before the markets open. Accenture shares rose 1.15 percent to $153.50 in after-hours trading.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
- Bed Bath & Beyond Inc. BBBY shares dropped over 5percent in after-hours trading despite reporting a third quarter earnings and sales beat. Comps were down 0.3 percent in the quarter. Bed Bath & Beyond shares dropped 5.41 percent to $23.24 in the after-hours trading session.
- After the closing bell, Cintas Corporation CTAS is estimated to post quarterly earnings at $1.26 per share on revenue of $1.58 billion. Cintas shares slipped 0.06 percent to $159.00 in after-hours trading.
- Herman Miller, Inc. MLHR posted in-line earnings for its second quarter on Wednesday. Herman Miller shares dropped 1.23 percent to $36.00 in the after-hours trading session.
- Analysts expect CarMax, Inc KMX to report quarterly earnings at $0.81 per share on revenue of $3.99 billion before the opening bell. CarMax shares gained 0.63 percent to $68.90 in after-hours trading.
- AEterna Zentaris Inc. (USA) AEZS reported the FDA approval of Macrilen for diagnosis of adult growth hormone deficiency. Aeterna Zentaris shares surged 61.60 percent to $3.24 in the after-hours trading session.
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in